Breaking News - The Fly

Open Search

DSNKY

Daiichi Sankyo

$

()

AstraZeneca reports results from DESTINY-Breast06 Phase 3 trial

AZN , DSNKY

4/29/2024 - 06:31am

ENHERTU approved for treatment of unresectable or metastatic HER2 positive

AZN , DSNKY

4/7/2024 - 06:04am

Daiichi Sankyo, Merck announe first patient dosed in REJOICE-Ovarian01 trial

DSNKY , MRK

4/3/2024 - 08:11am

Esperion reports CHMP issues positive opinions on Nilemdo and Nustendi

ESPR , DSNKY

3/22/2024 - 11:08am

AstraZeneca says datopotamab deruxtecan BLA accepted in U.S.

AZN , DSNKY

2/20/2024 - 06:34am

FDA grants AstraZeneca's ENHERTU priority review for HER2-directed treatment

AZN , DSNKY

1/29/2024 - 07:23am

Esperion, Daiichi Sankyo announce $125M amendment to collaboration

ESPR , DSNKY

1/3/2024 - 07:06am

Daiichi Sankyo upgraded to Buy from Hold at Jefferies

DSNKY

12/4/2023 - 04:24am

Daiichi Sankyo upgraded to Outperform from Market Perform at Bernstein

DSNKY

11/21/2023 - 05:37am

AstraZeneca: Enhertu demonstrated meaningful survival in Phase II trial

AZN , DSNKY

10/23/2023 - 10:56am

AstraZeneca says Dato-DXd improved progression-free survival in NSCLC trial

AZN , DSNKY

10/23/2023 - 10:40am

AstraZeneca reports 'positive' results from TROPION-Breast01 Phase III trial

AZN , DSNKY

10/23/2023 - 10:35am

AstraZeneca, Daiichi Sankyo's Enhertu approved in EU for certain NSCLC

AZN , DSNKY

10/23/2023 - 06:25am

Merck, Daiichi Sankyo announce development and commercialization collaboration

MRK , DSNKY

10/20/2023 - 10:20am

Daiichi Sankyo downgraded to Hold from Buy at Jefferies

DSNKY

9/25/2023 - 04:24am